Life Science Nation Newsletter  |  July 23, 2015  |  Issue 121

  The LSN Story   |   Investor Platform   |   Company Platform   |   RESI Conference   |   Fundraising Accelerator
Life Science Investor Mandates (July 16 - July 22)

Seeking HIT, Services, and Diagnostics 

Looking Opportunistically in the Life Science Space

Seeking Early Stage Partnerships in Immunology, Inflammation and Metabolic Diseases
Seeking Early Stage Life Science Investments
In This Issue

Therapeutic Financing Rounds in 2015: Gene Therapy Outpaces Antibodies in Early Stage Investment

    READ MORE

Video Recap: Strategic Life Science Investors at RESI Houston Event

LSN Summer Reading Series Chapter 9: "Global Target List - Match Your Firm with Investors That Are a Fit"

  READ MORE

LSN Videos
RESI@TMCx Investor Panel Videos

LSN in the News
Therapeutic Financing Rounds in 2015: Gene Therapy Outpaces Antibodies in Early Stage Investment
By Michael Quigley, Director of Research, LSN

It is no secret that 2015 has been a highly active year for deal-making in the life science space.  However, what is often overlooked is exactly where in the space those deals are taking place. Life Science Nation's financing rounds database contains detailed information on over 250 of these rounds that have taken place since January 1 of 2015. We track this data from a variety of sources however as many companies and investors chose not to disclose this information this should be viewed as a sample of the entire data set of financings. With this article will highlight what our data tells us about the rounds that have taken place thus far in 2015 for therapeutics companies around the globe.

 

The first cut worth examining is the types of technologies that received funding... 

 

  READ MORE

 

 

Video Recap: Strategic Life Science Investors at RESI Houston Event
By Nono Hu, Senior Manager, Branding & Messaging, LSN

On June 8, 2015, the Redefining Early Stage Investments (RESI) Conference came to Texas Medical Center (TMC), the largest medical complex in the world. In order to fill in those that missed out, LSN has released a recap video which captures the happenings and buzz at TMC's 100,000+ ft² accelerator space...

 

Video Recap of RESI@TMCx 2015

 

  READ MORE

LSN Summer Reading Series Chapter 9: "Global Target List - Match Your Firm with Investors That Are a Fit"

By Lucy Parkinson, Senior Research Manager, LSN    

 

Last week, we provided an overview of the infrastructure required to execute an outbound campaign. This week, we take a deeper look at how to build your target list of investors.

 

Chapter 9: "Global Target List - Match Your Firm with Investors That Are a Fit" explains the importance of finding alignment between your life science company and an investor's interests. Here we outline how to use information on past financing rounds to uncover potential investors, and how to screen these leads to find active investors that may be interested in your company's technology. Finally, we'll anatomize an investment mandate, and examine the factors that determine fit, including your location, the type of product you're developing, and the stage of development your asset has reached... 

 

Click here to download/print the PDF.

 

  READ MORE